TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04617327

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hypofractionation
Description: Shorter radiation therapy means that a higher dose will be given on a daily basis. The goal is to target microscopic disease and decrease the chances of local recurrence.~Organs at risk (OAR) will receive doses following the constraints from the Timmerman tables used for reference when using 5 or more fractions of EBRT.~Treatment will be delivered every 2nd day, for a maximum of 3 fractions per week. Daily pretreatment Image Guided Radiotherapy Images (IGRT) (Cone-Beam CT - CBCT) will be co-registered with the CT simulation dataset to adjust patient position before each treatment by matching the bone adjacent to the planned tumour volume (PTV). Treatment will be administered if there is \<3 mm in any dimension, or rotation is \<3 degrees. If the isocentre set-up exceeds 3 mm at any given treatment session, the treatment couch will be translated to restore its planned position.
Study: NCT02577120

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Epiceram Skin Barrier Function
Description: Epiceram is a non-sterile, viscous, lipid-rich emulsion
Study: NCT01091350

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Diprifusor (Target-controlled infusion)
Description: Two TCI devices with different Teo and same Marsh PK model
Study: NCT00222261

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aspirin
Description: Aspirin 160 mg once daily for two years

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: clopidogrel
Description: clopidogrel 75 mg once daily for two years
Study: NCT01131585

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Active laser photocoagulation
Description: Active laser photocoagulation procedure at baseline and reapplied if needed at intervals no shorter than 3 months from the last treatment.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Active laser photocoagulation
Description: Active laser photocoagulation procedure at baseline and reapplied if needed at intervals no shorter than 3 months from the last treatment.
Study: NCT01091350

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Orchestra (Target-controlled infusion)
Description: Two TCI devices with different Teo and same Marsh PK model
Study: NCT01483573

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: neural mobilization
Description: stretch the nerve

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: straight leg raise
Description: stretch the hamstring
Study: NCT01131585

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sham injections
Description: Sham intravitreal injections at baseline, 30, 60 and 90 days and if needed, reapplied at intervals no shorter than 28 days from last treatment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Description: Ranibizumab 0.5 mg/0.05 ml intravitreal injection at baseline, 30, 60 and 90 days and if needed, reapplied at intervals no shorter than 28 days from last treatment.
Study: NCT02577120

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Vaseline Petroleum Jelly
Description: A skin protectant used for temporarily protecting minor cuts, scraps, burns, and helps to protect and help relieve chapped or cracked skin and lips.
Study: NCT03112850

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hearing aid
Description: LOF hearing aid

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hearing aid
Description: LOF hearing aid

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Auditory Training

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Auditory Training
Study: NCT03666702

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Upper limb physiotherapy programme
Description: Web-based physio programme

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Usual physiotherapy care

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual physiotherapy care
Study: NCT02588755

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TACE+Tegafur
Description: Tegafur: 40mg bid for 3 continuous months in 4 months. TACE: 4 or 8 weeks after resection.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TACE
Description: TACE alone
Study: NCT04411095

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measuring thoracic rotation mobility
Description: Measuring the thoracic rotation mobility with a goniometer, from a standardized position

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Measuring thoracic rotation mobility
Description: Measuring the thoracic rotation mobility with a goniometer, from a standardized position
Study: NCT02148770

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurofeedback
Description: Networks involved in eating behaviour can be modified by neurofeedback training. We will perform a neurofeedback task using the technology of fMRI-based Brain Computer Interface (BCI). BCI approaches based on real-time fMRI (rtfMRI) allow voluntary regulation of brain regions. For the rtfMRI, a well-established setup will be used which translates the blood oxygen level dependent (BOLD) signal of a specific brain region of interest into a visual signal (e.g. moving bar) in real time using brain voyager® and matlab. The study will include 1 training-sessions In the up-regulation condition subjects will learn to up regulate their dlPFC. In the sham-condition subjects are get the same instructions, however they will receive sham feedback.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Neurofeedback
Description: Networks involved in eating behaviour can be modified by neurofeedback training. We will perform a neurofeedback task using the technology of fMRI-based Brain Computer Interface (BCI). BCI approaches based on real-time fMRI (rtfMRI) allow voluntary regulation of brain regions. For the rtfMRI, a well-established setup will be used which translates the blood oxygen level dependent (BOLD) signal of a specific brain region of interest into a visual signal (e.g. moving bar) in real time using brain voyager® and matlab. The study will include 1 training-sessions In the up-regulation condition subjects will learn to up regulate their dlPFC. In the sham-condition subjects are get the same instructions, however they will receive sham feedback.
Study: NCT01047397

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1278863A
Description: 25mg, 50mg, 100mg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching placebo
Study: NCT00400205

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Docetaxel 75 mg/m2, intravenous infusion over 1 hour, mixed with normal saline per institutional standard, day 1 and then every 3 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin 100 mg/m2, intravenous infusion over 30 minutes to 3 hours, day 1 and then every 3 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Description: 5-fluorouracil 1000 mg/m2/day, 24 hour continuous infusion over 4 days, every 3 weeks.
Study: NCT04076137

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Targeted T-cell armed with bispecific antibody (Decitabine)
Description: In this study, 10 patients eligible for the study were clinically screened for intravenous infusion of targeted activated T cells,every participant has a unique identification number and emergency letter which have the information of group.
Study: NCT04352530

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Communication
Description: Spoken word poems set to images performed by youth who wrote the poems. Videos were produced by The Bigger Project and were posted publicly to the Bigger Picture Project website and YouTube. Duration of videos ranges from 2 minutes to 6 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Communication
Description: Spoken word poems set to images performed by youth who wrote the poems. Videos were produced by The Bigger Project and were posted publicly to the Bigger Picture Project website and YouTube. Duration of videos ranges from 2 minutes to 6 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Communication
Description: Spoken word poems set to images performed by youth who wrote the poems. Videos were produced by The Bigger Project and were posted publicly to the Bigger Picture Project website and YouTube. Duration of videos ranges from 2 minutes to 6 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Communication
Description: Spoken word poems set to images performed by youth who wrote the poems. Videos were produced by The Bigger Project and were posted publicly to the Bigger Picture Project website and YouTube. Duration of videos ranges from 2 minutes to 6 minutes.
Study: NCT02405104

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: chlorzoxazone
Description: ATC-code: M03BB03

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: chlorzoxazone
Description: ATC-code: M03BB03

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: THA
Description: Surgical treatment of osteoarthrosis in the hip, by replacement.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: THA
Description: Surgical treatment of osteoarthrosis in the hip, by replacement.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TKA
Description: Surgical treatment of osteoarthrosis in the knee, by replacement.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: TKA
Description: Surgical treatment of osteoarthrosis in the knee, by replacement.
Study: NCT03068390

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RICHH Intervention
Description: Whole health cardiovascular disease (CVD) self-care risk reduction intervention

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Referral to primary care provider
Study: NCT03818633

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Elastic abdominal binder
Description: Each woman in the intervention group is fitted with an elastic abdominal binder at the time of procedure completion just before leaving the operating room. The binder is placed snuggly tight (keeping in mind patient's comfort) on top of the hospital gown with the incision positioned at the middle part of the binder. The patients are encouraged to wear binders at all time. However, periods of break from wearing the binder are allowed at their convenience.
Study: NCT04768998

Intervention type: OTHER
Intervention: Observational of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings
Description: Observatory Cohorts focusing (I) on subjects after SARS-CoV-2 infection that are recruited from the general population (POP), and on subjects with acute SARS-CoV-2 infections recruited (II) in university hospital high-care settings or (III) general health care.
Study: NCT04352530

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Health Communication
Description: Spoken word poems set to images performed by youth who wrote the poems. Videos were produced by The Bigger Project and were posted publicly to the Bigger Picture Project website and YouTube. Duration of videos ranges from 2 minutes to 6 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Communication
Description: Spoken word poems set to images performed by youth who wrote the poems. Videos were produced by The Bigger Project and were posted publicly to the Bigger Picture Project website and YouTube. Duration of videos ranges from 2 minutes to 6 minutes.
Study: NCT04768998

Intervention type: OTHER
Intervention: Observational of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings
Description: Observatory Cohorts focusing (I) on subjects after SARS-CoV-2 infection that are recruited from the general population (POP), and on subjects with acute SARS-CoV-2 infections recruited (II) in university hospital high-care settings or (III) general health care.

Intervention type: OTHER
Intervention: Observational of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings
Description: Observatory Cohorts focusing (I) on subjects after SARS-CoV-2 infection that are recruited from the general population (POP), and on subjects with acute SARS-CoV-2 infections recruited (II) in university hospital high-care settings or (III) general health care.
Study: NCT04352530

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Communication
Description: Spoken word poems set to images performed by youth who wrote the poems. Videos were produced by The Bigger Project and were posted publicly to the Bigger Picture Project website and YouTube. Duration of videos ranges from 2 minutes to 6 minutes.
Study: NCT06123416

Intervention type: BEHAVIORAL
Intervention: Expressive Writing
Description: Caregivers complete three 20-min writing sessions in which they write about an assigned topic - emotional or non-emotional.

Intervention type: BEHAVIORAL
Intervention: Expressive Writing
Description: Caregivers complete three 20-min writing sessions in which they write about an assigned topic - emotional or non-emotional.
Study: NCT03653078

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Three dimensional printed digital guide
Description: A CAD/CAM printed plate with a channel for mini-screw insertion
Study: NCT01421368

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir 1% vaginal gel
Description: Tenofovir 1% gel is supplied as a clear, transparent, viscous gel packaged in pre-filled single use applicators. Each applicator contains 4.0 mL of tenofovir gel (equal to 4.4 gm) at a concentration of 1% (weight for weight) formulated in purified water with edetate disodium, citric acid, glycerin, methylparaben, propylparaben and hydroxyethylcellulose, and is pH adjusted to 4-5

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir 1% vaginal gel
Description: Tenofovir 1% gel is supplied as a clear, transparent, viscous gel packaged in pre-filled single use applicators. Each applicator contains 4.0 mL of tenofovir gel (equal to 4.4 gm) at a concentration of 1% (weight for weight) formulated in purified water with edetate disodium, citric acid, glycerin, methylparaben, propylparaben and hydroxyethylcellulose, and is pH adjusted to 4-5
Study: NCT01196234

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel/Carboplatin/Gefitinib
Description: paclitaxel (175mg/m2 on day 1)/carboplatin (AUC 5 on day 1)/daily gefitinib 250mg/day during day 2-15

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel/Carboplatin
Description: paclitaxel (175mg/m2 on day 1)/carboplatin (AUC 5 on day 1)
Study: NCT01421368

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Depo-medroxyprogesterone acetate (DMPA)
Description: DMPA is an intramuscular injectable contraceptive containing 150 mg of medroxyprogesterone acetate. It is FDA approved for 12 weeks of use per injection.
Study: NCT00842036

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Reinforcement and Family Training
Description: Community Reinforcement and Family Training (CRAFT) is an intervention designed for the concerned significant other (CSO) of a drug or alcohol using loved one. The CRAFT intervention consists of approximately 12 sessions lasting 45-60 minutes. The goal of the CRAFT intervention is to train the CSO in new ways to interact with the person of concern (PC). There are four components that the CSO is trained on which include awareness training, community reinforcement training, treatment entry training, and CSO mood enhancement.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment Entry Training
Description: Treatment Entry Training (TEnT) is a component of the Community Reinforcement and Family Training intervention and it is currently under investigation to determine if it is sufficient to produce the primary and most consistent outcome of CRAFT- treatment entry of the drug user. The intervention will consist of a minimum of 4 sessions and a maximum of 6 sessions that are each 45-60 minutes long. TEnT will include awareness training, safety training, and the Treatment Entry Training component of CRAFT.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: 12- step Al/Nar- Anon Facilitation
Description: The underlying philosophy of the 12- step approach for concerned significant others (CSO) is that the CSO is powerless to control the drinker/drug user and must detach, focusing instead on accepting the situation and on strengthening his or her mental health. Eight content areas are discussed with the CSO over the course of the intervention. There will be a minimum of 8 sessions and a maximum of 12 sessions that are each 45-60 minutes long.
Study: NCT02988557

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: walking on a treadmill with a sloped surface
Description: walking on a treadmill with a sloped surface
Study: NCT01421368

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral contraceptive: LNG 150 mcg and EE 30 mcg
Description: Each pill contains LNG 150 mcg (the active levorotatory enantiomer of norgestrel) and EE 30 mcg. Each pack contains 21 active pills and 7 placebo pills
Study: NCT02988557

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: treadmill
Description: walking on a treadmill with a sloped surface
Study: NCT03116815

Intervention type: OTHER
Group type: OTHER
Intervention: Direct input of home blood pressure readings via MyChart
Description: Participants will record home blood pressure readings directly into the electronic health record via the MyChart application
Study: NCT03593447

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: non-cirrhotic subjects. low TG-2349+ low DAG181+Ribavirin
Description: Group1: TG-2349 200 mg + DAG181 100 mg + Ribavirin 1000 mg or 1200 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: non-cirrhotic subjects. high TG-2349+ high DAG181+Ribavirin
Description: Group2: TG-2349 400 mg + DAG181 200 mg + Ribavirin 1000 mg or 1200 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: non-cirrhotic subjects. low TG-2349+ low DAG181
Description: Group 3: TG-2349 200 mg + DAG181 100 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: non-cirrhotic subjects. high TG-2349+ high DAG181
Description: Group 4: TG-2349 400 mg + DAG181 200 mg
Study: NCT04235465

Intervention type: OTHER
Intervention: Dynamic Gait Index
Description: The Dynamic Gait Index (DGI) measures functionality and dynamic balance in walking and stair climbing. The DGI consists of 8 items including normal gait on flat ground, gait with speed changes, gait with horizontal head movements, gait with vertical head movements, gait and pivot turn, gait and step over an obstacle, gait around obstacles and steps up and downstairs. The performance on each item is rated on a 4-point scale ranging from 0 (severe disorder) to 3 (independent walking). The total score is 24.

Intervention type: OTHER
Intervention: Dynamic Gait Index
Description: The Dynamic Gait Index (DGI) measures functionality and dynamic balance in walking and stair climbing. The DGI consists of 8 items including normal gait on flat ground, gait with speed changes, gait with horizontal head movements, gait with vertical head movements, gait and pivot turn, gait and step over an obstacle, gait around obstacles and steps up and downstairs. The performance on each item is rated on a 4-point scale ranging from 0 (severe disorder) to 3 (independent walking). The total score is 24.
Study: NCT03593447

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cirrhotic subjects. high TG-2349+ high DAG181+Ribavirin
Description: Group 5: TG-2349 400 mg + DAG181 200 mg + Ribavirin 1000 mg or 1200 mg_

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cirrhotic subjects. high TG-2349+ high DAG181
Description: Group6: TG-2349 400 mg + DAG181 200 mg
Study: NCT04253860

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcutaneous electrical neurostimulation
Description: Sessions of 30 minutes of TENS will be applied three times a week during 90 days

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical neurostimulation
Description: Sessions of 30 minutes of TENS will be applied three times a week during 90 days
Study: NCT02398123

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Transversus abdominis plane block
Description: Children who received transversus aAbdominis plane block with 0.25% bupivacaine with epinephrine 1 mL/kg guided by ultrasound

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Caudal block
Description: Children who received caudal 0.25% bupivacaine 1 mL/kg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Bupivacaine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Study: NCT03424551

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: vibrator
Description: Local or whole body vibration was applied at six different frequencies
Study: NCT01652833

Intervention type: OTHER
Intervention: Physician Survey
Description: Eligible physicians will be contacted via telephone to perform the physician survey. A standardised questionnaire will be used to collect information about the physician's awareness of the correct indication and appropriate administration of Vectibix and the physician's experience in the administration of Vectibix treatment in the previous 6 months
Study: NCT03600753

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: culturomic
Description: Culturomic is a high-throughput culture strategy based on the multiplication of culture conditions coupled with the rapid identification of bacteria by MALDI-TOF (Matrix-Assisted Laser Desorption / Ionization-Time-Of-Flight) mass spectrometry

Intervention type: OTHER
Group type: OTHER
Intervention: culturomic
Description: Culturomic is a high-throughput culture strategy based on the multiplication of culture conditions coupled with the rapid identification of bacteria by MALDI-TOF (Matrix-Assisted Laser Desorption / Ionization-Time-Of-Flight) mass spectrometry
Study: NCT00560404

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methoxy polyethylene glycol-epoetin beta [Mircera]
Description: 120, 200 or 360 micrograms sc monthly (starting dose)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epoetin alfa
Description: As prescribed
Study: NCT01827943

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temsirolimus
Description: Temsirolimus
Study: NCT00501085

Intervention type: DEVICE
Intervention: LAP-BAND AP Adjustable Gastric Banding System
Description: Reduction of food intake due to creation of smaller stomach pouch.
Study: NCT02975453

Intervention type: DRUG
Intervention: Rivaroxaban (Xarelto, BAY59-7939)
Description: As prescribed by the treating physician
Study: NCT04759092

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation (tDCS)
Description: Apply 30min low dose (2mA) transcranial current stimulation on the scalp every day for four months.